Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Importance: There is uncertainty about whether prolonged infusions of β-lactam antibiotics improve clinically important outcomes in critically ill adults with sepsis or septic shock. Objective: To determine whether prolonged β-lactam antibiotic infusions are associated with a reduced risk of death in critically ill adults with sepsis or septic shock compared with intermittent infusions. Data Sources: The primary search was conducted with MEDLINE (via PubMed), CINAHL, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov from inception to May 2, 2024. Study Selection: Randomized clinical trials comparing prolonged (continuous or extended) and intermittent infusions of β-lactam antibiotics in critically ill adults with sepsis or septic shock. Data Extraction and Synthesis: Data extraction and risk of bias were assessed independently by 2 reviewers. Certainty of evidence was evaluated with the Grading of Recommendations Assessment, Development and Evaluation approach. A bayesian framework was used as the primary analysis approach and a frequentist framework as the secondary approach. Main Outcomes and Measures: The primary outcome was all-cause 90-day mortality. Secondary outcomes included intensive care unit (ICU) mortality and clinical cure. Results: From 18 eligible randomized clinical trials that included 9108 critically ill adults with sepsis or septic shock (median age, 54 years; IQR, 48-57; 5961 men [65%]), 17 trials (9014 participants) contributed data to the primary outcome. The pooled estimated risk ratio for all-cause 90-day mortality for prolonged infusions of β-lactam antibiotics compared with intermittent infusions was 0.86 (95% credible interval, 0.72-0.98; I2 = 21.5%; high certainty), with a 99.1% posterior probability that prolonged infusions were associated with lower 90-day mortality. Prolonged infusion of β-lactam antibiotics was associated with a reduced risk of intensive care unit mortality (risk ratio, 0.84; 95% credible interval, 0.70-0.97; high certainty) and an increase in clinical cure (risk ratio, 1.16; 95% credible interval, 1.07-1.31; moderate certainty). Conclusions and Relevance: Among adults in the intensive care unit who had sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions was associated with a reduced risk of 90-day mortality compared with intermittent infusions. The current evidence presents a high degree of certainty for clinicians to consider prolonged infusions as a standard of care in the management of sepsis and septic shock. Trial Registration: PROSPERO Identifier: CRD42023399434
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2 · Cited by 5,177
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Conference, F. T. I. S. D., Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., et al. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1662-x · Cited by 2,871
IntHout, J., Ioannidis, J. P., & Borm, G. F. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-25 · Cited by 2,419
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090
Self-citationSchandelmaier, S., Briel, M., Varadhan, R., Schmid, C. H., Devasenapathy, N., Hayward, R. A., Gagnier, J., Borenstein, M., van der Heijden, G. J. M. G., Dahabreh, I. J., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200077 · Cited by 749
Turner, R. M., Jackson, D., Wei, Y., Thompson, S. G., & Higgins, J. P. T. (2015) · Statistics in Medicine · doi:10.1002/sim.6381 · Cited by 410
Dulhunty, J. M., Roberts, J. A., Davis, J. S., Webb, S. A. R., Bellomo, R., Gomersall, C., Shirwadkar, C., Eastwood, G. M., Myburgh, J., Paterson, D. L., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis856 · Cited by 394
Self-citationRoberts, J. A., Abdul-Aziz, M.-H., Davis, J. S., Dulhunty, J. M., Cotta, M. O., Myburgh, J., Bellomo, R., & Lipman, J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0024oc · Cited by 379
Self-citationRoberts, J. A., Kirkpatrick, C. M. J., Roberts, M. S., Robertson, T. A., Dalley, A. J., & Lipman, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp139 · Cited by 347
Self-citationVardakas, K. Z., Voulgaris, G. L., Maliaros, A., Samonis, G., & Falagas, M. E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30615-1 · Cited by 327
Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package
Röver, C. (2020) · Journal of Statistical Software · doi:10.18637/jss.v093.i06 · Cited by 310
Abdul-Aziz, M. H., Sulaiman, H., Mat-Nor, M.-B., Rai, V., Wong, K. K., Hasan, M. S., Abd Rahman, A. N., Jamal, J. A., Wallis, S. C., Lipman, J., et al. (2016) · Intensive Care Medicine · doi:10.1007/s00134-015-4188-0 · Cited by 308
Self-citationA Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
Dulhunty, J. M., Roberts, J. A., Davis, J. S., Webb, S. A. R., Bellomo, R., Gomersall, C., Shirwadkar, C., Eastwood, G. M., Myburgh, J., Paterson, D. L., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0857oc · Cited by 264
Self-citationA systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
Roberts, J. A., Webb, S., Paterson, D., Ho, K. M., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a0054d · Cited by 225
Self-citationRoberts, J. A., Kirkpatrick, C. M. J., Roberts, M. S., Dalley, A. J., & Lipman, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.008 · Cited by 188
Self-citationChytra, I., Stepan, M., Benes, J., Pelnar, P., Zidkova, A., Bergerova, T., Pradl, R., & Kasal, E. (2012) · Critical Care · doi:10.1186/cc11405 · Cited by 174
Dulhunty, J. M., Brett, S. J., De Waele, J. J., Rajbhandari, D., Billot, L., Cotta, M. O., Davis, J. S., Finfer, S., Hammond, N. E., Knowles, S., et al. (2024) · JAMA · doi:10.1001/jama.2024.9779 · Cited by 171
Self-citationRoberts, J. A., Joynt, G. M., Lee, A., Choi, G., Bellomo, R., Kanji, S., Mudaliar, M. Y., Peake, S. L., Stephens, D., Taccone, F. S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa224 · Cited by 151
Self-citationRoberts, J. A., Boots, R., Rickard, C. M., Thomas, P., Quinn, J., Roberts, D. M., Richards, B., & Lipman, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl478 · Cited by 137
Self-citationMonti, G., Bradić, N., Marzaroli, M., Konkayev, A. K., Fominskiy, E. V., Kotani, Y., Likhvantsev, V. V., Momesso, E., Владимирович, Н. П., Lobreglio, R., et al. (2023) · JAMA · doi:10.1001/jama.2023.10598 · Cited by 135
Self-citationDoleman, B., Freeman, S. C., Lund, J. N., Williams, J. P., & Sutton, A. J. (2020) · Research Synthesis Methods · doi:10.1002/jrsm.1414 · Cited by 134
Mounton, J. W., & Vinks, A. A. T. M. M. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.1.5 · Cited by 121
Rafati, M. R., Rouini, M. R., Mojtahedzadeh, M., Najafi, A., Tavakoli, H., Gholami, K., & Fazeli, M. R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.02.020 · Cited by 120
Continuous beta-lactam infusion in critically ill patients: the clinical evidence
Abdul-Aziz, M. H., Dulhunty, J. M., Bellomo, R., Lipman, J., & Roberts, J. A. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-37 · Cited by 108
Self-citationCefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen
Georges, B., Conil, J.-M., Cougot, P., Decun, J.-F., Archambaud, M., Seguin, T., Chabanon, G., Virenque, C., Houin, G., & Saivin, S. (2005) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp43360 · Cited by 104
Jamal, J., Nor, M. B. M., Nor, F. S. M., Udy, A. A., Wallis, S. C., Lipman, J., & Roberts, J. A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.09.009 · Cited by 77
Self-citationZhao, H., Gu, J. P., Lyu, J., Liu, D., Wang, Y., Liu, F., Zhu, F., & An, Y. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.205859 · Cited by 77
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation
Shekar, K., Abdul-Aziz, M. H., Cheng, V., Burrows, F. S., Buscher, H., Cho, Y., Corley, A., Diehl, A., Gilder, E., Jakob, S. M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202207-1393oc · Cited by 73
Self-citationKondo, Y., Ota, K., Imura, H., Hara, N., & Shime, N. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00490-z · Cited by 58
Jamal, J., Roberts, D. M., Udy, A. A., Nor, M. B. M., Nor, F. S. M., Wallis, S. C., Lipman, J., & Roberts, J. A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.014 · Cited by 45
Self-citationDoleman, B., Mathiesen, O., Jakobsen, J. C., Sutton, A. J., Freeman, S. C., Lund, J. N., & Williams, J. P. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.01.004 · Cited by 38
Abdul-Aziz, M. H., Portunato, F., & Roberts, J. A. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000681 · Cited by 38
Self-citationDhaese, S. A. M., Heffernan, A. J., Liu, D. C., Abdul-Aziz, M. H., Stove, V. V., Tam, V. H., Lipman, J., Roberts, J. A., & Waele, J. J. D. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00919-6 · Cited by 32
Self-citationMirjalili, M., Zand, F., Karimzadeh, I., Masjedi, M., Sabetian, G., Mirzaei, E., & Vazin, A. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154170 · Cited by 28
Li, X., Long, Y., Wu, G., Li, R., Zhou, M., He, A., & Jiang, Z. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01222-w · Cited by 19
Lokhandwala, A., Patel, P., Isaak, A. K., Yousaf, R. F., Maslamani, A. N. J., Khalil, S. K., Riaz, E., & Hirani, S. (2023) · Cureus · doi:10.7759/cureus.46990 · Cited by 8
Álvarez, C., Nócua-Báez, L. C., Ortíz, G., Torres, J. C., Montenegro, G., Cervera, W., Gómez, A. P. M., & Zuluaga, L. F. (2024) · Antibiotics · doi:10.3390/antibiotics13030229 · Cited by 5
Abdul-Aziz, M. H., Hammond, N. E., Brett, S. J., Cotta, M. O., Waele, J. J. D., Tanna, G. L. D., Dulhunty, J. M., Elkady, H., Eriksson, L., Hasan, M. S., et al. (2023) · medRxiv · doi:10.1101/2023.05.15.23289889 · Cited by 1
Self-citation
Cited by
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationOptimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11
Metadata
- Authors
- Abdul-Aziz, M. H., Hammond, N. E., Brett, S. J., Cotta, M. O., De Waele, J. J., Devaux, A., Di Tanna, G. L., Dulhunty, J. M., Elkady, H., Eriksson, L., Hasan, M. S., Khan, A. B., Lipman, J., Liu, X., Monti, G., Myburgh, J., Novy, E., Omar, S., Rajbhandari, D., Roger, C., Sjövall, F., Zaghi, I., Zangrillo, A., Delaney, A., & Roberts, J. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2024-08-27
- Volume
- 332
- Issue
- 8
- Pages
- 638
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4399585721
- Cited by
- 180
- References
- 48
- FWCI
- 42.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.